| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6125466 | Osteoarthritis and Cartilage | 2013 | 7 Pages |
Abstract
Aggrecan and COMP circulating levels contribute to identification of phenotype-specific RKOA incidence. These data suggest potentially protective role of aggrecan in cartilage loss, as measured by JSN. High COMP levels are risk factors for development of RKOA, as assessed by K/L scores.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
O. Blumenfeld, F.M.K. Williams, D.J. Hart, T.D. Spector, N. Arden, G. Livshits,